Cargando…

Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens

Mice deficient in central components of classical NF-κB signaling have low levels of circulating natural IgM antibodies and fail to respond to immunization with T-independent type 2 (TI-2) antigens. A plausible explanation for these defects is the severely reduced numbers of B-1 and marginal zone B...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Gabriel K., Ádori, Monika, Stark, Julian M., Khoenkhoen, Sharesta, Arnold, Carrie, Beutler, Bruce, Karlsson Hedestam, Gunilla B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771772/
https://www.ncbi.nlm.nih.gov/pubmed/26973645
http://dx.doi.org/10.3389/fimmu.2016.00065
_version_ 1782418441948364800
author Pedersen, Gabriel K.
Ádori, Monika
Stark, Julian M.
Khoenkhoen, Sharesta
Arnold, Carrie
Beutler, Bruce
Karlsson Hedestam, Gunilla B.
author_facet Pedersen, Gabriel K.
Ádori, Monika
Stark, Julian M.
Khoenkhoen, Sharesta
Arnold, Carrie
Beutler, Bruce
Karlsson Hedestam, Gunilla B.
author_sort Pedersen, Gabriel K.
collection PubMed
description Mice deficient in central components of classical NF-κB signaling have low levels of circulating natural IgM antibodies and fail to respond to immunization with T-independent type 2 (TI-2) antigens. A plausible explanation for these defects is the severely reduced numbers of B-1 and marginal zone B (MZB) cells in such mice. By using an ethyl-N-nitrosourea mutagenesis screen, we identified a role for the atypical IκB protein IκBNS in humoral immunity. IκBNS-deficient mice lack B-1 cells and have severely reduced numbers of MZB cells, and thus resemble several other strains with defects in classical NF-κB signaling. We analyzed mice heterozygous for the identified IκBNS mutation and demonstrate that these mice have an intermediary phenotype in terms of levels of circulating IgM antibodies and responses to TI-2 antigens. However, in contrast to mice that are homozygous for the IκBNS mutation, the heterozygous mice had normal frequencies of B-1 and MZB cells. These results suggest that there is a requirement for IκBNS expression from two functional alleles for maintaining normal levels of circulating natural IgM antibodies and responses to TI-2 antigens.
format Online
Article
Text
id pubmed-4771772
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-47717722016-03-11 Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens Pedersen, Gabriel K. Ádori, Monika Stark, Julian M. Khoenkhoen, Sharesta Arnold, Carrie Beutler, Bruce Karlsson Hedestam, Gunilla B. Front Immunol Immunology Mice deficient in central components of classical NF-κB signaling have low levels of circulating natural IgM antibodies and fail to respond to immunization with T-independent type 2 (TI-2) antigens. A plausible explanation for these defects is the severely reduced numbers of B-1 and marginal zone B (MZB) cells in such mice. By using an ethyl-N-nitrosourea mutagenesis screen, we identified a role for the atypical IκB protein IκBNS in humoral immunity. IκBNS-deficient mice lack B-1 cells and have severely reduced numbers of MZB cells, and thus resemble several other strains with defects in classical NF-κB signaling. We analyzed mice heterozygous for the identified IκBNS mutation and demonstrate that these mice have an intermediary phenotype in terms of levels of circulating IgM antibodies and responses to TI-2 antigens. However, in contrast to mice that are homozygous for the IκBNS mutation, the heterozygous mice had normal frequencies of B-1 and MZB cells. These results suggest that there is a requirement for IκBNS expression from two functional alleles for maintaining normal levels of circulating natural IgM antibodies and responses to TI-2 antigens. Frontiers Media S.A. 2016-03-01 /pmc/articles/PMC4771772/ /pubmed/26973645 http://dx.doi.org/10.3389/fimmu.2016.00065 Text en Copyright © 2016 Pedersen, Ádori, Stark, Khoenkhoen, Arnold, Beutler and Karlsson Hedestam. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Pedersen, Gabriel K.
Ádori, Monika
Stark, Julian M.
Khoenkhoen, Sharesta
Arnold, Carrie
Beutler, Bruce
Karlsson Hedestam, Gunilla B.
Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title_full Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title_fullStr Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title_full_unstemmed Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title_short Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens
title_sort heterozygous mutation in iκbns leads to reduced levels of natural igm antibodies and impaired responses to t-independent type 2 antigens
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771772/
https://www.ncbi.nlm.nih.gov/pubmed/26973645
http://dx.doi.org/10.3389/fimmu.2016.00065
work_keys_str_mv AT pedersengabrielk heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT adorimonika heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT starkjulianm heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT khoenkhoensharesta heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT arnoldcarrie heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT beutlerbruce heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens
AT karlssonhedestamgunillab heterozygousmutationinikbnsleadstoreducedlevelsofnaturaligmantibodiesandimpairedresponsestotindependenttype2antigens